文献速递膀胱癌与上尿路尿路上皮癌

外科医生评分卡提升膀胱肿瘤电切术肌层采样并改善非肌层浸润性膀胱癌复发结局

Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer.
PubMed 文献 · J Urol · 2020-10-06

该回顾性研究评估了向外科医生分发个人肌层采样率评分卡对经尿道膀胱肿瘤电切术质量及肿瘤学结局的影响。结果显示评分卡分发后12个月内肌层采样率从36%升至54%(p=0.001),且与3年复发风险降低相关(HR 0.63,95%CI 0.40-0.99)。

要点

  • 分发个人评分卡可显著提高经尿道膀胱肿瘤电切术的肌层采样率。
  • 评分卡与3年复发风险降低独立相关(HR 0.63,95%CI 0.40-0.99)。
  • 病理报告肌层检出率在评分卡分发后也显著改善。

核心结论

  • 创建并分发个人外科医生评分卡可改善经尿道膀胱肿瘤电切术的肌层采样,并与疾病复发风险降低相关。

研究设计与样本

  • 回顾性审查2006年1月至2018年2月的经尿道膀胱肿瘤电切术记录,提取病理报告和标本中肌层存在情况。
  • 创建并分发个人外科医生评分卡,比较分发前与分发后12个月的肌层采样率。
  • 通过病历回顾比较评分卡分发前后3年复发和进展结局。

主要发现

  • 评分卡分发后12个月内肌层采样率从36%(1,250/3,488)升至54%(202/373)(p=0.001)。
  • Ta肿瘤肌层采样率从30%(448/1,500)升至55%(91/165)(p<0.001),T1肿瘤从47%(183/390)升至72%(42/58)(p<0.001)。
  • 所有样本病理报告肌层率从73%(2,530/3,488)升至90%(334/373)(p<0.001),Ta从75%(1,127/1,500)升至94%(155/165)(p<0.001),T1从93%(362/390)升至100%(58/58)(p=0.04)。
  • 多因素Cox回归分析显示,外科医生评分卡与3年复发风险降低相关(HR 0.63,95%CI 0.40-0.99)。

临床怎么用

  • 可考虑通过创建和分发个人肌层采样率评分卡来提升经尿道膀胱肿瘤电切术质量。
  • 质量评估经尿道膀胱肿瘤电切术可能有助于改善非肌层浸润性膀胱癌患者的结局。

局限性

  • 本研究为回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The presence of detrusor muscle is essential for accurate staging of T1 cancers. Detrusor muscle presence can be a quality indicator of transurethral resection of bladder tumor for nonmuscle invasive bladder cancer. We hypothesized that increasing surgeon awareness of personal and institutional detrusor muscle sampling rates could improve resection quality and long-term oncologic outcomes. MATERIALS AND METHODS: A retrospective review of transurethral resections of bladder tumor from 1/2006 to 2/2018 was performed. The presence of detrusor muscle in the pathology report and transurethral resection specimen were extracted from records. Individual surgeon scorecards were created and distributed. Rates of detrusor muscle sampling were compared prior to and 12 months after distribution. Chart review was done to compare 3-year recurrence and progression outcomes before and after distribution of scorecards. RESULTS: The rate of detrusor muscle sampling increased from 36% (1,250/3,488) to 54% (202/373) (p=0.001) in the 12 months after scorecard distribution, ie from 30% (448/1,500) to 55% (91/165) (p <0.001) in Ta tumors and from 47% (183/390) to 72% (42/58) (p <0.001) in T1 tumors. Pathological reporting of muscle also improved for all samples (73%, 2,530/3,488 to 90%, 334/373, p <0.001), Ta (75%, 1,127/1,500 to 94%, 155/165, p <0.001) and T1 (93%, 362/390 to 100%, 58/58, p=0.04). On multivariate Cox regression analysis, the surgeon scorecard was associated with decreased 3-year risk of recurrence (HR 0.63, 95% CI 0.40-0.99). CONCLUSIONS: Creation and distribution of individual surgeon scorecards improved detrusor muscle sampling on transurethral resection and was associated with decreased risk of disease recurrence. Quality evaluation of transurethral resection of bladder tumor may contribute to improved outcomes of patients with nonmuscle invasive bladder cancer.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Das A, Cohen JE, Ko OS, et al. Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer. J Urol. 2020. PMID: 33021430. doi:10.1097/JU.0000000000001372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。